Show simple item record

dc.contributor.authorHarrold, Leslie R.
dc.contributor.authorMazor, Kathleen M.
dc.contributor.authorNegron, Amarie
dc.contributor.authorOgarek, Jessica
dc.contributor.authorFirneno, Cassandra L.
dc.contributor.authorYood, Robert A.
dc.date2022-08-11T08:09:24.000
dc.date.accessioned2022-08-23T16:29:24Z
dc.date.available2022-08-23T16:29:24Z
dc.date.issued2013-09-01
dc.date.submitted2013-05-17
dc.identifier.citation<p>Harrold LR, Mazor KM, Negron A, Ogarek J, Firneno C, Yood RA. Primary care providers' knowledge, beliefs and treatment practices for gout: results of a physician questionnaire. Rheumatology (Oxford). 2013 Sep;52(9):1623-9. doi:10.1093/rheumatology/ket158. <a href="http://dx.doi.org/10.1093/rheumatology/ket158" target="_blank">Link to article on publisher's site</a></p>
dc.identifier.issn1462-0324 (Linking)
dc.identifier.doi10.1093/rheumatology/ket158
dc.identifier.pmid23620554
dc.identifier.urihttp://hdl.handle.net/20.500.14038/37235
dc.description.abstractObjective. We sought to examine primary care providers' gout knowledge and reported treatment patterns in comparison with current treatment recommendations. Methods. We conducted a national survey of a random sample of US primary care physicians to assess their treatment of acute, intercritical and tophaceous gout using published European and American gout treatment recommendations and guidelines as a gold standard. Results. There were 838 respondents (response rate of 41%), most of whom worked in private practice (63%) with >16 years experience (52%). Inappropriate dosing of medications in the setting of renal disease and lack of prophylaxis when initiating urate-lowering therapy (ULT) accounted for much of the lack of compliance with treatment recommendations. Specifically for acute podagra, 53% reported avoidance of anti-inflammatory drugs in the setting of renal insufficiency, use of colchicine at a dose of ≤2.4 mg/day and no initiation of a ULT during an acute attack. For intercritical gout in the setting of renal disease, 3% would provide care consistent with the recommendations, including initiating a ULT at the appropriate dose with dosing titration to a serum urate level of ≤6 mg/dl and providing prophylaxis. For tophaceous gout, 17% reported care consistent with the recommendations, including ULT use with dosing titration to a serum urate level of ≤6 mg/dl and prophylaxis. Conclusion. Only half of primary care providers reported optimal treatment practices for the management of acute gout and
dc.language.isoen_US
dc.relation<a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Retrieve&list_uids=23620554&dopt=Abstract">Link to Article in PubMed</a>
dc.relation.urlhttp://dx.doi.org/10.1093/rheumatology/ket158
dc.subjectGout
dc.subjectPrimary Health Care
dc.subjectGout knowledge
dc.subjectMedication use
dc.subjectTreatment practices
dc.subjectClinical Epidemiology
dc.subjectHealth Services Research
dc.subjectMusculoskeletal Diseases
dc.subjectPrimary Care
dc.subjectRheumatology
dc.titlePrimary care providers' knowledge, beliefs and treatment practices for gout: results of a physician questionnaire
dc.typeJournal Article
dc.source.journaltitleRheumatology (Oxford, England)
dc.source.volume52
dc.source.issue9
dc.identifier.legacycoverpagehttps://escholarship.umassmed.edu/meyers_pp/651
dc.identifier.contextkey4151968
html.description.abstract<p>Objective. We sought to examine primary care providers' gout knowledge and reported treatment patterns in comparison with current treatment recommendations.</p> <p>Methods. We conducted a national survey of a random sample of US primary care physicians to assess their treatment of acute, intercritical and tophaceous gout using published European and American gout treatment recommendations and guidelines as a gold standard.</p> <p>Results. There were 838 respondents (response rate of 41%), most of whom worked in private practice (63%) with >16 years experience (52%). Inappropriate dosing of medications in the setting of renal disease and lack of prophylaxis when initiating urate-lowering therapy (ULT) accounted for much of the lack of compliance with treatment recommendations. Specifically for acute podagra, 53% reported avoidance of anti-inflammatory drugs in the setting of renal insufficiency, use of colchicine at a dose of ≤2.4 mg/day and no initiation of a ULT during an acute attack. For intercritical gout in the setting of renal disease, 3% would provide care consistent with the recommendations, including initiating a ULT at the appropriate dose with dosing titration to a serum urate level of ≤6 mg/dl and providing prophylaxis. For tophaceous gout, 17% reported care consistent with the recommendations, including ULT use with dosing titration to a serum urate level of ≤6 mg/dl and prophylaxis.</p> <p>Conclusion. Only half of primary care providers reported optimal treatment practices for the management of acute gout and</p>
dc.identifier.submissionpathmeyers_pp/651
dc.contributor.departmentDepartment of Orthopedics and Physical Rehabilitation
dc.contributor.departmentDepartment of Medicine, Division of Rheumatology
dc.contributor.departmentMeyers Primary Care Institute
dc.source.pages1623-9


This item appears in the following Collection(s)

Show simple item record